Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Beta Bionics, Inc.NASDAQ: BBNX
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt remains negative
Q1 FY2026 net debt was -$23.29M, compared with -$35.48M a year earlier.
Context
- Net debt amounted to 7.7% of total assets at the end of Q1 FY2026, down 2.8 pp from a year earlier.
- Net debt grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether net debt keeps rising in the next quarterly balance sheet after a +34.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- (24.27M) USD
- Year-over-year change
- -4.7%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (24.27M) | -4.7% |
| FY2024 | 2024-12-31 | (23.18M) | -3.7% |
| FY2023 | 2023-12-31 | (22.34M) | +5.1% |
| FY2022 | 2022-12-31 | (23.54M) | — |
Net Debt vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +34.3% is the 3rd highest of 7, against a peer median of +22.3%.
- Net debt amounts to 7.7% of total assets for BBNX, versus a peer median of 13.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | DKK 95.65B DKK | +18.3% | +99.6% | 16.1% | |
| Mar 2026 | $555.41M USD | +26.3% | +12.7% | 48.2% | |
| Jun 2026 | $413.5M USD | -2.6% | -25.5% | 13.1% | |
| Mar 2026 | $383.84M USD | +619196.8% | +22.2% | 51.6% | |
| Jun 2026 | $293.4M USD | -79.3% | -32.0% | 4.5% | |
| Mar 2026 | -$12.44M USD | +83.2% | — | 4.6% | |
| Mar 2026 | -$23.29M USD | +34.3% | — | 7.7% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | -$148M USD | — | — | 3.1% |
| Peer median (excluding BBNX) | — | +22.3% | +12.7% | 13.1% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.